Bio Essence Corporation
BIOE
$0.40
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 485.68% | 2,071.08% | 7,419.48% | 64.70% | -41.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 485.68% | 2,071.08% | 7,419.48% | 64.70% | -41.25% |
| Cost of Revenue | 338.82% | 162.54% | 26.01% | -61.98% | -62.54% |
| Gross Profit | 557.95% | 255.63% | 663.36% | 82.99% | 67.13% |
| SG&A Expenses | -21.88% | 171.14% | 100.51% | 58.59% | 95.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.35% | 2,543.11% | 339.50% | 81.56% | 126.71% |
| Operating Income | 295.95% | 40.31% | 30.37% | -8.37% | -32.94% |
| Income Before Tax | 157.32% | 87.91% | -214.36% | -227.66% | -288.34% |
| Income Tax Expenses | 0.00% | 200.00% | 200.00% | -50.00% | -50.00% |
| Earnings from Continuing Operations | 157.24% | 87.84% | -215.13% | -226.78% | -287.00% |
| Earnings from Discontinued Operations | -- | 100.00% | 100.00% | 100.00% | 145.28% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 168.47% | 89.12% | -132.59% | -150.13% | -34.69% |
| EBIT | 295.95% | 40.31% | 30.37% | -8.37% | -32.94% |
| EBITDA | 296.44% | 47.81% | 32.63% | -8.87% | -34.48% |
| EPS Basic | 168.41% | 89.58% | -112.35% | -122.56% | -21.48% |
| Normalized Basic EPS | 157.20% | 88.11% | -213.89% | -207.95% | -256.94% |
| EPS Diluted | 236.52% | 89.58% | -112.35% | -122.56% | -21.48% |
| Normalized Diluted EPS | 157.20% | 88.11% | -213.89% | -207.95% | -256.94% |
| Average Basic Shares Outstanding | 0.00% | 2.74% | 2.74% | 5.08% | 8.84% |
| Average Diluted Shares Outstanding | 0.00% | 2.74% | 2.74% | 5.08% | 8.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |